Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

AGILE THERAPEUTICS INC (AGRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
09/28/2023 8-K Quarterly results
08/22/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, by and between Agile Therapeutics, Inc. and Scott Coiante"
08/09/2023 8-K Quarterly results
06/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/25/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Form of Series C-1 warrant",
"Form of Series C-2 warrant",
"Form of Series D Pre-funded warrant",
"Form of Placement Agent warrant",
"Form of Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A-1 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A-2 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series B Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor"
05/17/2023 8-K Other Events  Interactive Data
05/11/2023 8-K Quarterly results
Docs: "Twirla Delivers Single-Quarter Records for Retail and Non-Retail"
04/28/2023 8-K Quarterly results
04/26/2023 8-K Quarterly results
03/22/2023 8-K Quarterly results
Docs: "Fourth Quarter & Full Year 2022 Performance Updates"
03/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/27/2023 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Other Events, F...
01/26/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "OFFICES; BOOKS",
"TERMS OF PREFERRED STOCK",
"AGILE THERAPEUTICS ANNOUNCES DISTRIBUTION OF SERIES C PREFERRED STOCK TO ITS HOLDERS OF COMMON STOCK"
01/09/2023 8-K Investor presentation
11/07/2022 8-K Quarterly results
10/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/24/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Morgan, Lewis & Bockius LLP"
08/19/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/25/2022 8-K Quarterly results
07/13/2022 8-K Quarterly results
07/08/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
04/27/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financi...
04/26/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
04/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/30/2022 8-K Quarterly results
03/15/2022 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
03/11/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy